Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AL-38583 in Allergic Conjunctivitis
NCT01001091Phase 2Completed
- Sponsor
- Alcon Inc.
- Start
- Dec 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of cilomilast in allergic conjunctivitis (AC), sponsored by Alcon Inc.. Started Dec 2009; status: completed.
02
Drugs
cilomilast
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT01001091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01001091.